SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-04-000477
Filing Date
2004-04-09
Accepted
2004-04-08 17:52:22
Documents
9
Period of Report
2004-03-09

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN ISSUER form6k.htm 6-K 6504
4 PRESS RELEASE DATED MARCH 9, 2004 exhibit99-1.htm EX-99.1 7631
5 PRESS RELEASE DATED MARCH 15, 2004 exhibit99-2.htm EX-99.2 35723
6 MATERIAL CHANGE REPORT ? CARDIOME REPORTS YEAR END FINANCIALS AND GIVES OUTLOOK exhibit99-3.htm EX-99.3 5146
7 PRESS RELEASE DATED MARCH 29, 2004 exhibit99-4.htm EX-99.4 9089
8 MATERIAL CHANGE REPORT ? CARDIOME INITIATES CARDIAC SURGERY CLINICAL STUDY, REVI exhibit99-5.htm EX-99.5 7561
9 cardiome.gif GRAPHIC 7884
10 line.gif GRAPHIC 1142
11 yipsignature.jpg GRAPHIC 4552
  Complete submission text file 0001062993-04-000477.txt   87744
Mailing Address 3650 WESBROCK MALL V6S 2L2 VANCOUVER BC
Business Address 3650 WESBROOK MALL V6S 2L2 VANCOUVER BC A1 6042225577
CARDIOME PHARMA CORP (Filer) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1130
Type: 6-K | Act: 34 | File No.: 000-29338 | Film No.: 04725733
SIC: 2834 Pharmaceutical Preparations